Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
Dunger
D B
DB
Department of Paediatrics, University of Oxford, UK.
Cheetham
T D
TD
Holly
J M
JM
Matthews
D R
DR
D000293:Adolescent; D001682:Biological Availability; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D002940:Circadian Rhythm; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D011627:Puberty / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone